
Cancer Precision Screening & CAR-T
Early oncology screening and advanced cell-therapy pathway in one line.
A product-line-first program for UK patients who want faster treatment access, stronger clinical depth, and transparent pricing in China.
24-48h diagnostic turnaround
Tier-1 PET-CT, robotics, and CAR-T access
Transparent package ranges

Each line is mapped to real clinical strengths in China: speed, specialist volume, and advanced equipment.

Early oncology screening and advanced cell-therapy pathway in one line.

Robot-assisted total hip and total knee replacement with accelerated rehab planning.

Deep diagnostic workup for gynecology and reproductive health with integrated recovery planning.

High-density FUE transplantation and clinical laser hair removal in one aesthetic line.

Comprehensive picosecond skin management focused on visible efficacy and safety.

For stubborn eczema and psoriasis with TCM-Western integrated protocols.

Extraction, implants, fillings, whitening, and restorative pathways under one plan.
Each package highlights core China-side strengths with indicative timeline and pricing range.
Latest-generation PET-CT and high-throughput specialist review enable rapid risk triage.
High-volume clinical ecosystem with dedicated in-hospital monitoring protocols.
Robot-assisted procedures by high-volume orthopedic teams with structured rehab protocols.
Same-cycle endocrine, imaging, and minimally invasive diagnostics with integrated follow-up.
Physician-led FUE design and device-based hair removal with standardized aftercare.
Fast-iteration laser platforms with parameter protocols tuned for pigment-risk reduction.
TCM + Western joint protocol for eczema, psoriasis, and chronic dermatitis management.
Nano-composite filling materials, imported glass ionomer options, and digital restorative planning improve fit and durability; public extraction service-item references: CNY 10-48 (simple), CNY 85-119 (complex), CNY 143-315 (impacted), with CNY 45-200 add-ons by complexity.
Benchmark date: 2026-02-10. Source: 2026 UK-China Medical Tourism White Paper. Extraction figures above are public service-item references and do not include imaging, anesthesia, medication, or consumables.
Indicative range only. Final quote follows specialist review and treatment plan confirmation.
These articles capture the search intent we see most from UK patients before they submit a case.
For patients comparing NHS delays with a faster China pathway built around diagnostics, specialist review, and admission planning.
Read the NHS wait-time guideFocused on UK orthopedic demand around hip and knee replacement, robotic surgery access, and rehab-oriented planning.
Read the orthopedics guideFor UK families comparing whether a China oncology review can speed up diagnosis, treatment sequencing, and multidisciplinary clarity.
Read the cancer pathway guideFor couples comparing faster reproductive testing, partner coordination, and more compact fertility diagnostics in China.
Read the fertility guideShare your case and we will map the right China treatment line for you.
Get My China Treatment Plan